1-Methylpiperazine → 5-[4-(4-methylpiperazin-1-yl)-1,4-dioxo-3-(phenylmethyl)butyl]-5,6-dihydro-4H-thieno[3,4-c]pyrrole
反応式
C(N1C=CN=C1)(N1C=CN=C1)=O.[O:13]=[C:14]([N:27]1[CH2:31][C:30]2=[CH:32][S:33][CH:34]=[C:29]2[CH2:28]1)[CH2:15][CH:16]([CH2:20][C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1)[C:17]([OH:19])=O.[CH3:35][N:36]1[CH2:41][CH2:40][NH:39][CH2:38][CH2:37]1>O1CCCC1>[CH3:35][N:36]1[CH2:41][CH2:40][N:39]([C:17](=[O:19])[CH:16]([CH2:20][C:21]2[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=2)[CH2:15][C:14]([N:27]2[CH2:31][C:30]3=[CH:32][S:33][CH:34]=[C:29]3[CH2:28]2)=[O:13])[CH2:38][CH2:37]1参加物
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
0.55 g (3.39 mmol) of carbonyldiimidazole is added to a solution of 1 g (3.17 mmol) of γ-oxo-α-(phenylmethyl)-5,6-dihydro-4H-thieno[3,4-c]pyrrole-5-butanoic acid in 15 ml of dry tetrahydrofuran. The solution is stirred at room temperature for 1 h and then 0.42 ml (3.8 mmol) of 4-methylpiperazine is added and the solution is stirred at room temperature for 20 h. The mixture is then evaporated to dryness, the residue is dissolved in 50 ml of dichloromethane, and then the solution obtained is washed successively with twice 50 ml of a saturated sodium hydrogen carbonate solution and 20 ml of a saturated sodium chloride solution, dried over sodium sulphate and then evaporated to dryness. After recrystallization from ethanol, 1 g of a white solid is obtained.
後処理
- stirringthe solution is stirred at room temperature for 20 h
- customThe mixture is then evaporated to dryness
- dissolutionthe residue is dissolved in 50 ml of dichloromethane
- customthe solution obtained
- washis washed successively with twice 50 ml of a saturated sodium hydrogen carbonate solution and 20 ml of a saturated sodium chloride solution
- dry with materialdried over sodium sulphate
- customevaporated to dryness
- customAfter recrystallization from ethanol
出典と根拠
- ORDレコード
- ord-45f660b67d8d496da55afae62f216aa8
- 出典データセット
- uspto-grants-1999_02
- 特許番号
- US05869518
反応ノート
読み込み中…